Boston Scientific Corp
NYSE:BSX
Relative Value
The Relative Value of one
BSX
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 71.9 USD,
Boston Scientific Corp
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
BSX Competitors Multiples
Boston Scientific Corp Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
106.6B USD | 5.3 | 36.8 | 21.6 | 28.9 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
195.6B USD | 4.4 | 30 | 17.2 | 23.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
175.3B USD | 17.4 | 61.4 | 46.6 | 57.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
140B USD | 5.6 | 43.1 | 21.9 | 26.5 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
117.2B USD | 3.3 | 25.4 | 13.9 | 20.3 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
45.2B EUR | 1.9 | 21.4 | 11.8 | 16.7 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
48.7B USD | 11.3 | 45.9 | 32.6 | 36.1 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.9B USD | 8.1 | 45.6 | 25.1 | 27.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
47.1B USD | 2.1 | 26.8 | 10.5 | 17.7 | |
| US |
|
Resmed Inc
NYSE:RMD
|
36.8B USD | 6.8 | 24.8 | 17.5 | 19.5 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
34.5B USD | 1.7 | 16.5 | 11.8 | 14.3 |